Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling. - Rizzello C; Cancila V; Sangaletti S; Botti L; Ratti C; Milani M; Dugo M; Bertoni F; Tripodo C; Chiodoni C; Colombo MP (Molecular cancer, 2022)